Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new site revision entry (v3.5.2) was added and an older revision (v3.5.0) was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a new revision entry for v3.4.3 and removed the v3.4.2 entry from the version history.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed the government-funding notice and the v3.4.1 entry from the history.SummaryDifference0.7%

- Check84 days agoChange DetectedAdded a notice about a lapse in government funding and the NIH Clinical Center’s operating status with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check91 days agoChange DetectedThe history page now includes a glossary display option and uses green highlights for additions and red highlights for deletions to visualize changes, and retains the No FEAR Act Data section; the revision tag has been updated to Revision: v3.4.0.SummaryDifference1.0%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.